---
title: "Tempest Therapeutics, Inc. (TPST.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TPST.US.md"
symbol: "TPST.US"
name: "Tempest Therapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-05-21T15:56:36.407Z"
locales:
  - [en](https://longbridge.com/en/quote/TPST.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TPST.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TPST.US.md)
---

# Tempest Therapeutics, Inc. (TPST.US)

## Company Overview

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.tempesttx.com](https://www.tempesttx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.62 | 149 | - | - | - |
| PB | 32.46 | 427 | 4.61 | 2.53 | 1.93 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-03-31T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.79 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TPST.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TPST.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TPST.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TPST.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**